AVDL

Avadel Pharmaceuticals

112 hedge funds and large institutions have $806M invested in Avadel Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 34 increasing their positions, 27 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
112
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$15.6M
Puts
$4.96M
Net Calls
Net Calls Change

Top Buyers

1 +$31.6M
2 +$21.8M
3 +$11M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$6.88M
5
ABG
Ally Bridge Group
New York
+$4.9M

Top Sellers

1 -$21.2M
2 -$9.83M
3 -$5.71M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$4.98M
5
Marshall Wace
Marshall Wace
United Kingdom
-$4.32M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$173K
77
$171K
78
$169K
79
$169K
80
$168K
81
$160K
82
$146K
83
$141K
84
$131K
85
$120K
86
$90.6K
87
$83.5K
88
$56.5K
89
$50K
90
$49.8K
91
$39.3K
92
$36.3K
93
$34K
94
$32.5K
95
$28.3K
96
$28.2K
97
$18.4K
98
$17.7K
99
$14.1K
100
$14K